Literature DB >> 20659985

Reducing Clostridium difficile infection in acute care by using an improvement collaborative.

Maxine Power1, Neil Wigglesworth, Emma Donaldson, Paul Chadwick, Stephen Gillibrand, Donald Goldmann.   

Abstract

PROBLEM: In 2006, despite a focus on infection control, Salford Royal had the fourth highest rate of Clostridium difficile infection in north west England.
DESIGN: Interrupted time series in five collaborative wards (intervention group) and 35 non-collaborative wards (control group).
SETTING: University teaching hospital with 850 acute beds. KEY MEASURES FOR IMPROVEMENT: Number of cases of C difficile infection per 1000 occupied bed days. STRATEGIES FOR CHANGE: In February 2007, a newly formed antimicrobial team led the implementation of revised guidelines in all wards and departments. From March to December 2007, five wards participated in an improvement collaborative. Since December 2007, the changes from the collaborative have been collated and implemented throughout the organisation. EFFECTS OF CHANGE: At baseline the non-collaborative wards had 1.15 (95% CI 1.03 to 1.29) cases per 1000 occupied bed days. In August 2007 cases reduced 56% from baseline (0.51, 0.44 to 0.60), which has been maintained since that time. In the collaborative wards, there were 2.60 (2.11 to 3.17) cases per 1000 occupied bed days at baseline. A shift occurred in April 2007 representing a reduction of 73% (0.69, 0.50 to 0.91) from baseline, which has been maintained. LESSONS LEARNT: Careful use of antimicrobial drugs is important in reducing the number of cases of C difficile infection. A collaborative learning model can enable teams to test and implement changes that can accelerate, amplify, and sustain control of C difficile.

Entities:  

Mesh:

Year:  2010        PMID: 20659985     DOI: 10.1136/bmj.c3359

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  3 in total

Review 1.  Reducing Clostridium difficile in the Inpatient Setting: A Systematic Review of the Adherence to and Effectiveness of C. difficile Prevention Bundles.

Authors:  Anna K Barker; Caitlyn Ngam; Jackson S Musuuza; Valerie M Vaughn; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2017-03-27       Impact factor: 3.254

2.  Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study.

Authors:  Jeppe West Carstensen; Mahtab Chehri; Kristian Schønning; Steen Christian Rasmussen; Jacob Anhøj; Nina Skavlan Godtfredsen; Christian Østergaard Andersen; Andreas Munk Petersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-03       Impact factor: 3.267

3.  Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Emilie Dehlholm-Lambertsen; Bianca K Hall; Simon M D Jørgensen; Christine W Jørgensen; Mia E Jensen; Sara Larsen; Josephine S Jensen; Lars Ehlers; Jens F Dahlerup; Christian L Hvas
Journal:  Therap Adv Gastroenterol       Date:  2019-04-10       Impact factor: 4.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.